Gastmeier P, Geffers C, Brandt C, Zuschneid I, Sohr D, Schwab F, Behnke M, Daschner F, Rüden H
Institute for Medical Microbiology and Hospital Epidemiology, Medical University, Hannover, Germany.
J Hosp Infect. 2006 Sep;64(1):16-22. doi: 10.1016/j.jhin.2006.04.017. Epub 2006 Jul 3.
In recent years, several countries have established surveillance systems for nosocomial infections (NIs) on a national basis. Limited information has been published on the effectiveness of these national surveillance systems. The aim of this study was to investigate whether participation in the German national NI surveillance system [Krankenhaus Infektions Surveillance System (KISS)] resulted in reduced rates of NIs. Three major NIs were studied: ventilator-associated pneumonia (VAP) and central-venous-catheter-related primary bloodstream infections (CR-BSIs) in intensive care units (ICUs), and surgical site infections (SSIs) in surgical inpatients. Data were collected from January 1997 until December 2003. Only institutions that had participated in KISS for at least 36 months were considered for analysis. Data from the first 12 months of surveillance were compared with data from the second and third 12-month periods. One hundred and fifty ICUs and 133 surgical departments fulfilled the inclusion criteria. In their first year of participation in KISS, the ICUs had an average VAP rate of 11.2 per 1000 ventilator-days and a CR-BSI rate of 2.1 per 1000 catheter-days. The average SSI rate in the surgical inpatients was 1.6 per 100 operations in their first year of participation. Comparing the infection rates in the third year with the first year, the relative risk (RR) for VAP was 0.71 [95% confidence intervals (CI) 0.66-0.76] and the RR for CR-BSI was 0.80 (95% CI 0.72-0.90). The corresponding RR for SSI was 0.72 [95% CI 0.64-0.80]. Participation in KISS was associated with a significant reduction in these three NIs.
近年来,几个国家已在全国范围内建立了医院感染监测系统。关于这些国家监测系统的有效性,已发表的信息有限。本研究的目的是调查参与德国全国医院感染监测系统[医院感染监测系统(KISS)]是否能降低医院感染率。研究了三种主要的医院感染:重症监护病房(ICU)中的呼吸机相关性肺炎(VAP)和中心静脉导管相关原发性血流感染(CR-BSI),以及外科住院患者的手术部位感染(SSI)。数据收集时间为1997年1月至2003年12月。仅考虑参与KISS至少36个月的机构进行分析。将监测的前12个月的数据与第二和第三个12个月期间的数据进行比较。150个ICU和133个外科科室符合纳入标准。在参与KISS的第一年,ICU的VAP平均发生率为每1000个呼吸机日11.2例,CR-BSI发生率为每1000个导管日2.1例。参与的第一年,外科住院患者的SSI平均发生率为每100例手术1.6例。将第三年与第一年的感染率进行比较,VAP的相对风险(RR)为0.71[95%置信区间(CI)0.66-0.76],CR-BSI的RR为0.80(95%CI 0.72-0.90)。SSI的相应RR为0.72[95%CI 0.64-0.80]。参与KISS与这三种医院感染的显著降低相关。